» Articles » PMID: 18819704

Treatment of Type 2 Diabetes with Incretin-based Therapies

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2008 Sep 30
PMID 18819704
Citations 12
Authors
Affiliations
Soon will be listed here.
Citing Articles

Hormonal Gut-Brain Signaling for the Treatment of Obesity.

Roh E, Choi K Int J Mol Sci. 2023; 24(4).

PMID: 36834794 PMC: 9959457. DOI: 10.3390/ijms24043384.


Engineering an enhanced thrombin-based GLP-1 analog with long-lasting glucose-lowering and efficient weight reduction.

Pan H, Xie Y, Lu W, Chen Y, Lu Z, Zhen J RSC Adv. 2022; 9(53):30707-30714.

PMID: 35529389 PMC: 9072222. DOI: 10.1039/c9ra06771j.


Association of TyG Index with CT Features in Patients with Tuberculosis and Diabetes Mellitus.

Chen Y, Peng A, Chen Y, Kong X, Li L, Tang G Infect Drug Resist. 2022; 15:111-125.

PMID: 35068934 PMC: 8767160. DOI: 10.2147/IDR.S347089.


Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in....

Pugliese G, Penno G, Natali A, Barutta F, Di Paolo S, Reboldi G J Nephrol. 2019; 33(1):9-35.

PMID: 31576500 PMC: 7007429. DOI: 10.1007/s40620-019-00650-x.


The Bidirectional Relationship between Tuberculosis and Diabetes.

Yorke E, Atiase Y, Akpalu J, Sarfo-Kantanka O, Boima V, Dzifa Dey I Tuberc Res Treat. 2017; 2017:1702578.

PMID: 29270319 PMC: 5705893. DOI: 10.1155/2017/1702578.